Are you looking for read ebook online? Search for your book and save it on your Kindle device, PC, phones or tablets. Download Medicare Hospital Outlier Payments Warrant Increased Scrutiny PDF full book. Access full book title Medicare Hospital Outlier Payments Warrant Increased Scrutiny.
| Author | : CreateSpace Independent Publishing Platform |
| Publisher | : Createspace Independent Publishing Platform |
| Total Pages | : 36 |
| Release | : 2018-07-11 |
| Genre | : |
| ISBN | : 9781722765989 |
Medicare hospital outlier payments warrant increased scrutiny.
| Author | : United States. Department of Health and Human Services. Office of Inspector General |
| Publisher | : |
| Total Pages | : 18 |
| Release | : 2013 |
| Genre | : Critical care medicine |
| ISBN | : |
| Author | : Grace M. Carter |
| Publisher | : |
| Total Pages | : 116 |
| Release | : 1992 |
| Genre | : Diagnosis related groups |
| ISBN | : |
In FY 1989, the Health Care Financing Agency (HCFA) changed the amount it would pay for extremely long or costly Medicare hospital stays called outliers. Based on a 20% sample of Medicare hospitalizations as recorded in the Medicare Provider Analysis and Review (MEDPAR) file, the authors compared the distribution of outlier payments under the FY 1989 policy with the FY 1988 distribution under the previous policy; described the extent to which each policy provided reimbursement to the most costly cases and examined the distribution of outlier payments among other patient groups and among hospital groups; and estimated the effect of outlier payments on hospitals' financial risk using the methodology developed in Keeler et al. (1988). The authors examined three characteristics of stays that hospitals might have changed in response to the incentives inherent in outlier policy: (1) the resources provided to long-staying patients, (2) the discharge rate near the old outlier threshold, and (3) the concentration of very expensive cases in public hospitals in large urban areas. The outlier policy appears to have accomplished several goals. In particular, the new policy succeeded in: concentrating outlier funds on the costliest cases; providing more funds to hospitals with cases that are more costly than average for their Diagnosis Related Group (DRG); and decreasing risk by 5% from what it would have been if the policy had not changed. The study also identified two problems with existing outlier policy: (1) day outlier payments frequently exceed the cost of the services delivered; and (2) the formula for setting cost outlier thresholds produces less than optimum protection from risk. Although the changes were not large, the authors found some evidence that hospitals responded to the outlier policy change both by increasing length of stay and increasing the services delivered to the most costly patients. They judge that this analysis increases the strength of the argument for using case-based rather than hospital-based outlier payments.
| Author | : United States. Congress. Senate. Committee on Appropriations. Subcommittee on Departments of Labor, Health and Human Services, Education, and Related Agencies |
| Publisher | : |
| Total Pages | : 66 |
| Release | : 2004 |
| Genre | : Hospitals |
| ISBN | : |
| Author | : Alan T. Belasen |
| Publisher | : Routledge |
| Total Pages | : 409 |
| Release | : 2015-12-07 |
| Genre | : Business & Economics |
| ISBN | : 1317424972 |
Confronting Corruption in Business focuses on the contextual issues that trigger corruption to give the reader a more thorough understanding of destructive leadership. It provides students with a unique, critical perspective on issues of leadership, corruption, and policy in different countries, industries, and companies. While there isn’t a universally agreed upon definition of corruption in social sciences, it generally refers to efforts to secure wealth or power through misusing public power for private gain. This kind of destructive leadership is typically treated as an anomaly, but this book closes the gap in our understanding by highlighting the wider consequences of this behavior within business, and on an international level. Armed with this understanding, one also learns how to mitigate its causes and consequences. Edited by leading experts, the book includes contributions from scholars with international expertise on leadership, strategy, political science, finance, organizational change, and public policy. It is the first book to focus on corruption on the country level and within business, and students in international business, management, ethics, and leadership classes will find it a valuable read.
| Author | : Alain Vertes |
| Publisher | : Academic Press |
| Total Pages | : 846 |
| Release | : 2020-02-07 |
| Genre | : Science |
| ISBN | : 0128120339 |
Second Generation Cell and Gene-Based Therapies: Biological Advances, Clinical Outcomes, and Strategies for Capitalisation serves as the only volume to the market to bridge basic science, clinical therapy, technology development, and business in the field of cellular therapy/cytotherapy. After more than two decades of painstaking fundamental research, the concept of therapeutic cells (stem cells, genes, etc.), beyond the concept of vaccines, is reaching clinical trial, with mounting confidence in the safety and efficacy of these products. Nonetheless, numerous incremental technical advances remain to be achieved. Thus, this volume highlights the possible R&D paths, which will ultimately facilitate clinical delivery of cutting edge curative products. The next waves of innovation are reviewed in depth for hematopoietic stem cells, mesenchymal stem cells, tissue engineering, CAR-T cells, and cells of the immune system, as well as for enabling technologies such as gene and genome editing. Additionally, deep dives in product fundamentals, history of science, pathobiology of diseases, scientific and technological bases, and financing and technology adoption constraints are taken to unravel what will shape the cytotherapy industry to the horizon 2025 and beyond. The outcome is not simply a scientific book, but a global perspective on the nascent field combining science, business, and strategic fundamentals. Helps readers learn about the most current trends in cell-based therapy, their overall effectiveness from a clinical prospective, and how the industry is moving therapies forward for capitalization "Perspectives" section at the end of each chapter summarizes key learnings, hypotheses, and objectives highlighted and combines scientific and business insights Edited and authored by scientists representing both basic and clinical research and industry, presenting a complete story of the current state and future promise of cellular therapies
| Author | : Jerry Cromwell |
| Publisher | : RTI Press |
| Total Pages | : 388 |
| Release | : 2011-02-28 |
| Genre | : Medical |
| ISBN | : 1934831042 |
This book provides a balanced assessment of pay for performance (P4P), addressing both its promise and its shortcomings. P4P programs have become widespread in health care in just the past decade and have generated a great deal of enthusiasm in health policy circles and among legislators, despite limited evidence of their effectiveness. On a positive note, this movement has developed and tested many new types of health care payment systems and has stimulated much new thinking about how to improve quality of care and reduce the costs of health care. The current interest in P4P echoes earlier enthusiasms in health policy—such as those for capitation and managed care in the 1990s—that failed to live up to their early promise. The fate of P4P is not yet certain, but we can learn a number of lessons from experiences with P4P to date, and ways to improve the designs of P4P programs are becoming apparent. We anticipate that a “second generation” of P4P programs can now be developed that can have greater impact and be better integrated with other interventions to improve the quality of care and reduce costs.
| Author | : |
| Publisher | : |
| Total Pages | : 546 |
| Release | : 2017-11-27 |
| Genre | : |
| ISBN | : 9781683086857 |
In addition to reprinting the PDF of the CMS CoPs and Interpretive Guidelines, we include key Survey and Certification memos that CMS has issued to announced changes to the emergency preparedness final rule, fire and smoke door annual testing requirements, survey team composition and investigation of complaints, infection control screenings, and legionella risk reduction.
| Author | : National Academies of Sciences, Engineering, and Medicine |
| Publisher | : National Academies Press |
| Total Pages | : 483 |
| Release | : 2017-09-28 |
| Genre | : Medical |
| ISBN | : 0309459575 |
Drug overdose, driven largely by overdose related to the use of opioids, is now the leading cause of unintentional injury death in the United States. The ongoing opioid crisis lies at the intersection of two public health challenges: reducing the burden of suffering from pain and containing the rising toll of the harms that can arise from the use of opioid medications. Chronic pain and opioid use disorder both represent complex human conditions affecting millions of Americans and causing untold disability and loss of function. In the context of the growing opioid problem, the U.S. Food and Drug Administration (FDA) launched an Opioids Action Plan in early 2016. As part of this plan, the FDA asked the National Academies of Sciences, Engineering, and Medicine to convene a committee to update the state of the science on pain research, care, and education and to identify actions the FDA and others can take to respond to the opioid epidemic, with a particular focus on informing FDA's development of a formal method for incorporating individual and societal considerations into its risk-benefit framework for opioid approval and monitoring.
| Author | : Medicare Payment Advisory Commission (U.S.) |
| Publisher | : |
| Total Pages | : 184 |
| Release | : 1998 |
| Genre | : Hospitals |
| ISBN | : |
